Guizhou Sanli Pharmaceutical Co.,Ltd (SHA:603439)
China · Delayed Price · Currency is CNY 12.06
-0.01 (-0.08%)
Feb 27, 2026, 3:00 PM CST
SHA:603439 Market Cap
SHA:603439 has a market cap or net worth of 4.88 billion as of February 27, 2026. Its market cap has decreased by -4.46% in one year.
Market Cap
4.88B
Enterprise Value
5.43B
Revenue
1.74B
Ranking
n/a
PE Ratio
30.18
Stock Price
12.06
Market Cap Chart
Since April 28, 2020, SHA:603439's market cap has increased from 4.31B to 4.88B, an increase of 13.27%. That is a compound annual growth rate of 2.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 26, 2026 | 4.89B | 3.16% |
| Dec 31, 2025 | 4.74B | -9.02% |
| Dec 31, 2024 | 5.20B | -32.74% |
| Dec 29, 2023 | 7.74B | 37.27% |
| Dec 30, 2022 | 5.64B | -13.05% |
| Dec 31, 2021 | 6.48B | -21.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tibet Duo Rui Pharmaceutical | 5.06B |
| Jianmin Pharmaceutical Group | 5.03B |
| Bide Pharmatech | 4.98B |
| Newland Pharmaceutical | 4.97B |
| Shanghai Jiaoda Onlly Co.,Ltd | 4.91B |
| Tibet Weixinkang Medicine | 4.84B |
| Shanghai Xiao Fang Pharmaceutical | 4.79B |
| Ningbo Menovo Pharmaceutical | 4.72B |